ArticleArchives of microbiology2025
The mechanism of action of nisin in promoting poultry through tight junction integrity and dendritic cell anti-inflammatory properties.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary Pediocin Supplementation Restores Intestinal Barrier Function and Microbiota Balance inMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance in microbes poses a global health threat, making the search for alternatives to antibiotic growth promoters (AGPs) in the livestock industry an urgent priority. Nisin, an antibacterial peptide widely used as a food preservative, can enhance the poultry growth performance. However, its efficacy requires high doses owing to its degradation by digestive enzymes. Moreover, the mechanisms underlying its effect remain unclear. We investigated the effects of nisin on antimicrobial activity, tight junction integrity, and anti-inflammatory response using intestinal microorganisms, epithelial cells, and immune cells. Nisin displayed broad antibacterial activity against Gram-positive bacteria, including both pathogenic and beneficial species such as lactic acid bacteria. In contrast, Gram-negative bacteria, such as Escherichia coli and Salmonella, were highly resistant to nisin. Moreover, nisin improved tight junction integrity at concentrations over 100 times lower than those required for antimicrobial activity. In addition, nisin reduced inflammation-related cytokines, including TNF-α, IL-1β, IL-6, and IL-12p70, secreted by dendritic cells at concentrations over five times lower than those needed for antimicrobial activity. Furthermore, the prototype of the enteric-coated nisin was effective under a state of dynamic equilibrium in the dissolution tests. Notably, nisin improved tight junction integrity at low concentrations, comparable to those of AGPs. Therefore, the results suggest that the growth-promoting effect of nisin is not due to antimicrobial action but rather to its ability to enhance tight junction integrity and reduce inflammation of dendritic cells, making it a potential alternative to AGPs without the risk of superbug emergence.
Indexed as
Identifiers
40464952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.